These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 776046)

  • 1. [Statistical evaluation of biochemical data by the method of discrimination analysis. Selection of the discriminant biochemical variables. Attempted biochemical discrimination of intrahepatic cholestasis, extrahepatic obstruction and liver cancer].
    Plomteux G; Toulet J; Albert A; Amrani N
    Ann Biol Clin (Paris); 1975; 33(6):411-22. PubMed ID: 776046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid concentrations in the diagnosis of hepatobiliary disease in the dog.
    Center SA; Baldwin BH; Erb HN; Tennant BC
    J Am Vet Med Assoc; 1985 Nov; 187(9):935-40. PubMed ID: 4055519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN; Alaupovic P
    Gastroenterology; 1976 Jul; 71(1):87-93. PubMed ID: 179911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs.
    Center SA; ManWarren T; Slater MR; Wilentz E
    J Am Vet Med Assoc; 1991 Jul; 199(2):217-26. PubMed ID: 1890031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminant analysis of biochemical parameters in liver disease.
    Olubuyide IO; Festing MF; Chapman C; Higginson J; Whicher JT
    Trop Gastroenterol; 1997; 18(1):15-9. PubMed ID: 9197166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [With primary liver carcinoma-associated cholestasis].
    Varga L; Jakabovits A; Brittig F
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():120-1. PubMed ID: 7483692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New liver tests emerging from specialistic research. Determination of serum bile-salts].
    Galeazzi R; Koch MM; Capurso L
    Minerva Med; 1980 Nov; 71(47):3473-5. PubMed ID: 7454102
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential diagnosis between benign and malignant biliary tract obstruction: discriminative usefulness of some clinical and laboratory data.
    Giusti G; Piccinino F; Sagnelli E; Pasquale G
    Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):374-9. PubMed ID: 1211064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-chemical diagnosis of the cholestasis syndrome].
    Ohlen J; Drescher M; Selmair H
    Fortschr Med; 1982 Jan; 100(1-2):10-15. PubMed ID: 6120134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast liver alkaline phosphatase isoenzyme in diagnosis of malignant biliary obstruction.
    Paritpokee N; Tangkijvanich P; Teerasaksilp S; Wiwanitkit V; Lertmaharit S; Tosukhowong P
    J Med Assoc Thai; 1999 Dec; 82(12):1241-6. PubMed ID: 10659568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver function tests].
    Marín-López E; Díaz L; Martínez F
    Rev Gastroenterol Mex; 1993; 58(2):145-53. PubMed ID: 7747025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
    Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
    J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of cholestasis.
    Leevy CM; Chen T; Zaki FG
    Adv Intern Med; 1971; 17():323-42. PubMed ID: 4950248
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-invasive diagnosis of liver cirrhosis: a comparison between four discriminant functions.
    Corrao G; Carle F; Valenti M; Aricò S; Galatola G; Tabone M; Di Orio F
    Rev Epidemiol Sante Publique; 1993; 41(2):123-30. PubMed ID: 8493390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B; Palynyczko Z
    Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on liver diseases using the indocyanine green test].
    Huoranszki F; Jakab M; Wittman I; Aszódi Z; Rendes E
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(4):295-302. PubMed ID: 4662802
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1992; 12(5):1687-93. PubMed ID: 1332581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.